Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial

by Pablo Francisco Belaunzarán-Zamudio, Livio Azzoni, David H. Canaday, Yanink N. Caro-Vega, Brian Clagget, Mohammed S Rassool, Benigno Rodriguez, Ian Sanne, Irini Sereti, Juan G. Sierra-Madero, Michael M. Lederman
Published 2017-05-01